Indo-Bangla Pharmaceuticals (DHA:IBP) Long-Term Capital Lease Obligation : BDT0.00 Mil (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Indo-Bangla Pharmaceuticals Long-Term Capital Lease Obligation?

Indo-Bangla Pharmaceuticals's Long-Term Capital Lease Obligation for the quarter that ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals Long-Term Capital Lease Obligation Historical Data

The historical data trend for Indo-Bangla Pharmaceuticals's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo-Bangla Pharmaceuticals Long-Term Capital Lease Obligation Chart

Indo-Bangla Pharmaceuticals Annual Data

Trend

Long-Term Capital Lease Obligation

Indo-Bangla Pharmaceuticals Semi-Annual Data

Long-Term Capital Lease Obligation

Indo-Bangla Pharmaceuticals (DHA:IBP) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Indo-Bangla Pharmaceuticals Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Indo-Bangla Pharmaceuticals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo-Bangla Pharmaceuticals (DHA:IBP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo-Bangla Pharmaceuticals Ltd (DHA:IBP) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot No. 183, 6th Floor, Block B, Ahmed Akbar Sobhan Road, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229

Website

http://www.indo-banglapharma.com

Indo-Bangla Pharmaceuticals Ltd is engaged in manufacturing, marketing and distribution of generic pharmaceuticals products which includes human drugs dosages form such as tablet, capsule, syrup, oral saline, suspension. The products of the company are sold in domestic market. The company has also applied for permission for production and selling of veterinary medicine.